The global mRNA synthesis & manufacturing market is poised for steady growth, projected to expand from USD 2.23 billion in 2024 to USD 2.96 billion by 2029, registering a compound annual growth rate (CAGR) of 5.8% during the forecast period. The market’s upward trajectory is being driven by increasing investments in mRNA-based technologies, particularly in vaccine development and advanced therapeutics.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105705347
According to the latest research report, the market encompasses a wide range of products, including consumables and instruments, as well as services such as synthesis, purification, and large-scale manufacturing. The expanding application scope of mRNA across cell and gene therapy (CGT) and vaccines continues to unlock new growth opportunities globally.
A key factor accelerating market growth is the heightened focus on mRNA-based vaccines, especially following their successful deployment during the COVID-19 pandemic. This success has catalyzed further research into mRNA applications for infectious diseases, cancer immunotherapies, and rare genetic disorders. In addition, technological advancements in mRNA synthesis, increasing outsourcing activities, and strategic collaborations among biotechnology and pharmaceutical companies are significantly contributing to market expansion.
However, the market faces certain challenges. High production costs and stringent regulatory frameworks governing mRNA-based product approvals may restrain growth to some extent. Despite these barriers, ongoing innovation and scaling capabilities are expected to mitigate these concerns over time.
Consumables Segment Dominates the Product Landscape
By product type, the mRNA synthesis & manufacturing market is segmented into consumables and instruments. In 2023, the consumables segment accounted for the largest market share. This dominance is attributed to the recurring demand for essential components such as nucleotides, enzymes (including RNA polymerase and reverse transcriptase), reagents, buffers, and kits used throughout transcription, purification, and analysis processes.
Unlike instruments, which are typically one-time investments, consumables require continuous replenishment, thereby driving consistent revenue generation within this segment.
Pharmaceutical & Biotechnology Companies to Lead End-User Growth
Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs) & contract development and manufacturing organizations (CDMOs). Among these, pharmaceutical and biotechnology companies are expected to register the highest growth rate during the forecast period.
This growth is largely fueled by increased investments in mRNA therapeutics, a growing pipeline of clinical-stage mRNA products, and rising demand for cell and gene therapies. Additionally, strategic partnerships and funding initiatives aimed at accelerating mRNA innovation are further strengthening this segment’s market position.
Asia Pacific Emerges as the Fastest-Growing Regional Market
Regionally, the mRNA synthesis & manufacturing market spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, Asia Pacific is anticipated to witness the fastest growth during the forecast period.
The region’s rapid expansion is driven by rising healthcare expenditure, increasing prevalence of cancer, and growing investments in biopharmaceutical research and development. Countries such as China, Japan, and India are emerging as key growth hubs due to favorable regulatory environments, cost advantages, and expanding biotechnology infrastructure.
Request Sample Pages-https://www.marketsandmarkets.com/requestsampleNew.asp?id=105705347
Key Industry Players
The report highlights several leading companies shaping the competitive landscape of the mRNA synthesis & manufacturing market, including Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), TriLink BioTechnologies (US), GenScript (US), Takara Bio Inc. (Japan), Lonza (Switzerland), and WuXi Biologics (Cayman) Inc. (China). These players are actively engaged in product innovation, strategic collaborations, and capacity expansions to strengthen their market presence.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com